Stock listing
NSE:SAILIFE SAI Life Sciences Ltd. Share Price
Home listing (NSE) of SAI Life Sciences Ltd.
Follow SAI Life Sciences Ltd. into a list and get an email when it puts out news.
Share price · NSE:SAILIFE
₹1,800.70 INR +12.60 (+0.7%)
Close on Nov 20, 2026
- Day range
- ₹1,776.90 – ₹1,829.90 INRNov 20, 2026
- Volume
- 617,750 sharesNov 20, 2026
- Market cap
- ₹382.6B INRAt the close on Nov 20, 2026 · price × 212.5M shares outstanding
- 52-week range
- ₹783.85 – ₹1,954.80 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹1.77B INRMedian day 513,959 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:SAILIFE · Home | ₹1,800.70 INR | +12.60 (+0.7%) | 617,750 | ₹1,780.00 | ₹1,829.90 | ₹1,776.90 | ₹1,788.10 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:SAILIFE · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹1,800.70 | +12.60 | +0.7% | ₹1,780.00 | ₹1,829.90 | ₹1,776.90 | 617,750 | |
| ₹1,788.10 | +36.60 | +2.1% | ₹1,751.50 | ₹1,819.20 | ₹1,750.40 | 1,187,141 | |
| ₹1,751.50 | -48.70 | -2.7% | ₹1,795.00 | ₹1,815.00 | ₹1,738.00 | 1,824,608 | |
| ₹1,800.20 | -128.60 | -6.7% | ₹1,928.80 | ₹1,948.70 | ₹1,785.40 | 1,272,620 | |
| ₹1,928.80 | +23.60 | +1.2% | ₹1,830.00 | ₹1,954.80 | ₹1,820.00 | 1,504,859 | |
| ₹1,905.20 | -13.40 | -0.7% | ₹1,910.20 | ₹1,926.90 | ₹1,881.00 | 1,031,716 | |
| ₹1,918.60 | +81.80 | +4.5% | ₹1,850.00 | ₹1,941.80 | ₹1,844.00 | 3,483,493 | |
| ₹1,836.80 | +51.70 | +2.9% | ₹1,738.80 | ₹1,897.30 | ₹1,699.00 | 10,122,189 | |
| ₹1,785.10 | +190.60 | +12.0% | ₹1,655.10 | ₹1,814.90 | ₹1,614.90 | 13,228,240 | |
| ₹1,594.50 | +48.40 | +3.1% | ₹1,560.80 | ₹1,599.00 | ₹1,548.60 | 546,480 | |
| ₹1,546.10 | -12.10 | -0.8% | ₹1,512.20 | ₹1,555.70 | ₹1,504.00 | 325,226 | |
| ₹1,558.20 | +15.90 | +1.0% | ₹1,565.00 | ₹1,573.30 | ₹1,522.90 | 400,023 | |
| ₹1,542.30 | -15.20 | -1.0% | ₹1,565.20 | ₹1,580.00 | ₹1,525.00 | 631,369 | |
| ₹1,557.50 | +61.80 | +4.1% | ₹1,499.40 | ₹1,568.00 | ₹1,496.00 | 1,261,868 | |
| ₹1,495.70 | +8.50 | +0.6% | ₹1,483.10 | ₹1,504.90 | ₹1,473.40 | 282,700 | |
| ₹1,487.20 | +1.00 | +0.1% | ₹1,473.80 | ₹1,515.00 | ₹1,461.00 | 375,450 | |
| ₹1,486.20 | +40.90 | +2.8% | ₹1,441.00 | ₹1,490.30 | ₹1,435.40 | 230,932 | |
| ₹1,445.30 | +50.00 | +3.6% | ₹1,380.00 | ₹1,450.00 | ₹1,375.00 | 280,035 | |
| ₹1,395.30 | -0.60 | 0.0% | ₹1,391.90 | ₹1,429.00 | ₹1,382.90 | 669,392 | |
| ₹1,395.90 | +2.30 | +0.2% | ₹1,390.00 | ₹1,407.80 | ₹1,371.00 | 176,826 | |
| ₹1,393.60 | -2.30 | -0.2% | ₹1,395.00 | ₹1,399.10 | ₹1,360.60 | 427,119 | |
| ₹1,395.90 | +6.50 | +0.5% | ₹1,381.00 | ₹1,412.60 | ₹1,370.40 | 290,389 | |
| ₹1,389.40 | -5.30 | -0.4% | ₹1,400.00 | ₹1,403.30 | ₹1,371.40 | 639,029 | |
| ₹1,394.70 | -37.40 | -2.6% | ₹1,432.00 | ₹1,444.70 | ₹1,390.00 | 631,706 | |
| ₹1,432.10 | -30.20 | -2.1% | ₹1,456.50 | ₹1,456.60 | ₹1,421.30 | 406,225 | |
| ₹1,462.30 | -9.00 | -0.6% | ₹1,472.00 | ₹1,479.80 | ₹1,426.70 | 724,740 | |
| ₹1,471.30 | -16.60 | -1.1% | ₹1,489.00 | ₹1,505.20 | ₹1,464.00 | 380,927 | |
| ₹1,487.90 | -17.70 | -1.2% | ₹1,509.80 | ₹1,518.90 | ₹1,470.60 | 429,336 | |
| ₹1,505.60 | -56.20 | -3.6% | ₹1,563.40 | ₹1,563.40 | ₹1,499.00 | 513,978 | |
| ₹1,561.80 | +3.70 | +0.2% | ₹1,558.00 | ₹1,590.00 | ₹1,544.10 | 656,465 | |
| ₹1,558.10 | +46.80 | +3.1% | ₹1,520.00 | ₹1,569.00 | ₹1,495.00 | 277,814 | |
| ₹1,511.30 | -29.90 | -1.9% | ₹1,549.50 | ₹1,557.90 | ₹1,501.00 | 325,814 | |
| ₹1,541.20 | 0.00 | 0.0% | ₹1,541.20 | ₹1,541.20 | ₹1,541.20 | 0 | |
| ₹1,541.20 | +16.70 | +1.1% | ₹1,516.00 | ₹1,556.90 | ₹1,493.10 | 584,535 | |
| ₹1,524.50 | -35.40 | -2.3% | ₹1,565.70 | ₹1,577.90 | ₹1,516.40 | 537,181 | |
| ₹1,559.90 | -22.90 | -1.4% | ₹1,576.00 | ₹1,594.50 | ₹1,550.00 | 356,685 | |
| ₹1,582.80 | -9.40 | -0.6% | ₹1,600.20 | ₹1,611.10 | ₹1,564.10 | 273,968 | |
| ₹1,592.20 | -2.70 | -0.2% | ₹1,590.00 | ₹1,623.40 | ₹1,581.00 | 265,877 | |
| ₹1,594.90 | -14.70 | -0.9% | ₹1,601.00 | ₹1,649.80 | ₹1,589.00 | 518,814 | |
| ₹1,609.60 | +9.10 | +0.6% | ₹1,606.90 | ₹1,633.40 | ₹1,600.20 | 265,789 | |
| ₹1,600.50 | -7.50 | -0.5% | ₹1,608.10 | ₹1,615.00 | ₹1,592.50 | 274,572 | |
| ₹1,608.00 | +7.50 | +0.5% | ₹1,614.00 | ₹1,631.00 | ₹1,601.00 | 368,349 | |
| ₹1,600.50 | +54.80 | +3.5% | ₹1,553.40 | ₹1,613.90 | ₹1,550.30 | 867,960 | |
| ₹1,545.70 | +6.60 | +0.4% | ₹1,537.90 | ₹1,569.60 | ₹1,530.20 | 443,745 | |
| ₹1,539.10 | -2.40 | -0.2% | ₹1,539.80 | ₹1,557.80 | ₹1,494.40 | 801,004 | |
| ₹1,541.50 | -43.50 | -2.7% | ₹1,587.90 | ₹1,601.00 | ₹1,535.80 | 433,185 | |
| ₹1,585.00 | 0.00 | 0.0% | ₹1,585.00 | ₹1,585.00 | ₹1,585.00 | 0 | |
| ₹1,585.00 | -6.10 | -0.4% | ₹1,590.00 | ₹1,616.10 | ₹1,571.40 | 1,170,229 | |
| ₹1,591.10 | -84.30 | -5.0% | ₹1,675.40 | ₹1,675.40 | ₹1,585.00 | 1,174,342 | |
| ₹1,675.40 | +28.30 | +1.7% | ₹1,647.30 | ₹1,697.00 | ₹1,642.00 | 1,332,770 | |
| ₹1,647.10 | +67.50 | +4.3% | ₹1,579.60 | ₹1,657.20 | ₹1,574.00 | 1,414,082 | |
| ₹1,579.60 | -4.70 | -0.3% | ₹1,590.00 | ₹1,599.80 | ₹1,567.40 | 456,700 | |
| ₹1,584.30 | +9.50 | +0.6% | ₹1,570.00 | ₹1,622.00 | ₹1,561.90 | 561,938 | |
| ₹1,574.80 | -12.20 | -0.8% | ₹1,588.00 | ₹1,630.00 | ₹1,559.90 | 1,633,705 | |
| ₹1,587.00 | +68.90 | +4.5% | ₹1,518.10 | ₹1,595.00 | ₹1,509.00 | 2,747,154 | |
| ₹1,518.10 | +58.40 | +4.0% | ₹1,460.10 | ₹1,560.00 | ₹1,460.10 | 2,643,744 | |
| ₹1,459.70 | -25.30 | -1.7% | ₹1,485.00 | ₹1,496.50 | ₹1,453.20 | 694,617 | |
| ₹1,485.00 | -3.20 | -0.2% | ₹1,489.90 | ₹1,506.30 | ₹1,473.80 | 228,815 | |
| ₹1,488.20 | +27.20 | +1.9% | ₹1,467.10 | ₹1,498.10 | ₹1,458.10 | 431,944 | |
| ₹1,461.00 | +5.50 | +0.4% | ₹1,462.00 | ₹1,477.80 | ₹1,453.60 | 232,305 | |
| ₹1,455.50 | +19.60 | +1.4% | ₹1,439.00 | ₹1,459.00 | ₹1,420.30 | 183,271 | |
| ₹1,435.90 | -21.50 | -1.5% | ₹1,457.60 | ₹1,462.10 | ₹1,432.00 | 263,540 | |
| ₹1,457.40 | -14.20 | -1.0% | ₹1,483.00 | ₹1,485.00 | ₹1,448.40 | 323,792 | |
| ₹1,471.60 | +49.40 | +3.5% | ₹1,436.60 | ₹1,484.20 | ₹1,436.40 | 513,940 |
- Ticker
- NSE:SAILIFE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- NSE
- Currency
- INR
What changed lately
Latest news release · Nov 5, 2026
Sai Life Sciences Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "Press Release on Financial Results ".
Latest earnings call · Nov 6, 2026
SAI Life Sciences (NSE:SAILIFE) Q2 2027 Earnings Call
Replay and transcript
Latest deck · Nov 6, 2026
Q2 FY2027 Earnings Presentation
Earnings · 34 slides
Latest news
Sai Life Sciences Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "Press Release on Financial Results ".
Nov 5, 2026
Closed ₹1,785.10 (+12.0%) on Nov 6, 2026
Sai Life Sciences Ltd. Press Release Aug 06 2026
Aug 6, 2026
Closed ₹1,365.20 (-3.4%) on Aug 7, 2026
Press Release May 14 2026
May 14, 2026
Closed ₹1,090.90 (-1.9%) on May 15, 2026
Press Release May 11 2026
May 11, 2026
Closed ₹1,083.80 (-3.8%) on May 12, 2026
Sai Life Sciences to Recruit 700+ Professionals in FY27
Feb 20, 2026
Closed ₹941.40 (+0.5%) on Feb 20, 2026
Press Release Feb 05 2026
Feb 5, 2026
Closed ₹849.80 (+4.8%) on Feb 6, 2026
Press Release Jan 28 2026
Jan 28, 2026
Closed ₹827.75 (-2.3%) on Jan 29, 2026
Mabtech and Sai Life Sciences Announce Strategic Collaboration to Advance Immunology Research with EYRA Platform at Sai Boston Site
Jan 28, 2026
Closed ₹827.75 (-2.3%) on Jan 29, 2026
Press Release Dec 19 2025
Dec 19, 2025
Closed ₹911.75 (-0.6%) on Dec 22, 2025
Sai Life Sciences Releases Sustainability Report 2024–25
Dec 19, 2025
Closed ₹917.60 (+4.7%) on Dec 19, 2025
SAI Life Sciences Ltd. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 10 in the last 12 months · 26 in all · newest Nov 5, 2026 · oldest 2025
- Calls
- 1 call with a replay · 1 with a transcript · latest Nov 6, 2026
- Decks
- 10 decks · latest Nov 6, 2026
Where SAI Life Sciences Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:SAILIFE · Home listing · This page | NSE | India | INR |
| BSE:SAILIFE | BSE | India | INR |
Valuation
P/E 106× against a median of 28.3×: the highest of 7 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹382.6B INR
- P/E
- 106×
- EV/sales
- 17.0×
- EV/EBITDA
- 58.1×
- Price/book
- 15.4×
- Gross margin
- 35.5%
- Operating margin
- 21.5%
- Net margin
- 16.1%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| SAI Life Sciences Ltd. · NSE:SAILIFE | US$4.13B | US$4.13B | 106× | 17.0× | 58.1× | 15.4× | 16.1% | 0.0× | n/a |
| Caris Life Sciences, Inc. · NASDAQ:CAI | US$4.97B | US$4.60B | 51.7× | 4.4× | 28.3× | 7.8× | 9.2% | 0.6× | 1.90 |
| Hangzhou Tigermed Consulting Co., Ltd. Class A · SZSE:300347 | US$4.87B | US$4.78B | n/a | 4.2× | n/a | 1.7× | −5.3% | 0.1× | n/a |
| DiaSorin S.p.A. · MIL:DIA | US$4.78B | US$4.60B | 28.0× | 3.5× | 11.7× | 2.8× | 13.0% | 0.0× | n/a |
| GRAIL, Inc. · NASDAQ:GRAL | US$4.46B | US$3.76B | n/a | 22.6× | n/a | 1.8× | −243.8% | 0.0× | 2.83 |
| BillionToOne, Inc. · NASDAQ:BLLN | US$3.83B | US$3.36B | 77.6× | 7.7× | 59.6× | 6.8× | 11.3% | 0.2× | 1.35 |
| CareDx, Inc. · NASDAQ:CDNA | US$3.68B | US$3.43B | 28.6× | 6.9× | n/a | 7.9× | 25.9% | 0.0× | 1.26 |
| Tecan Group AG · SIX:TECN | US$3.50B | US$3.49B | n/a | 3.3× | 34.0× | 2.6× | −12.5% | 0.2× | n/a |
| Piramal Pharma Limited · NSE:PPLPHARMA | US$3.42B | US$3.97B | n/a | 3.8× | 30.6× | 3.9× | −2.1% | 0.7× | n/a |
| Siegfried Holding AG · SIX:SFZN | US$3.40B | US$4.38B | 16.9× | 2.8× | 12.0× | 2.9× | 12.7% | 0.9× | n/a |
| Apeloa Pharmaceutical Co. Ltd. Class A · SZSE:000739 | US$3.29B | US$2.84B | 27.3× | 2.1× | n/a | 3.4× | 9.1% | 0.1× | n/a |
| Median of the others | US$3.76B | US$3.86B | 28.3× | 4.0× | 29.5× | 3.1× | 9.1% | 0.1× | 1.63 |
Forecasts
Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.
- Price target
- 1876.14 INR · Analysts' mean
- EPS, year to Mar 2027
- 20.98 · 6 analysts
- Revenue, year to Mar 2027
- 27.58B · 5 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Krishna Kanumuri | Managing Director and CEO |
| Siva Chittor | Whole-Time Director & Chief Financial Officer |
| Runa Karan | Company Secretary, Compliance Officer & Legal Head |
| Sriram Gopalakrishnan | Vice President |
Board
| Director | Role |
|---|---|
| K. Ranga Raju | Chairman |
| Kanumuri Ranga Raju | Chairman |
| Dinesh V Patel | Independent Director |
| Ramesh G Iyer | Independent Director |
| Suchita Sharma | Independent Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| SAI Life Sciences (NSE:SAILIFE) Q2 2027 Earnings Call | Fri, Nov 06, 2026 · 4:36 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 5, 2026 · After close | +11.9% |
| Q1 2027 | Aug 6, 2026 · After close | −3.4% |
| Q4 2026 | May 14, 2026 · After close | −1.9% |
| Q3 2026 | Feb 5, 2026 · After close | +4.8% |
| Q2 2026 | Nov 6, 2025 · Before open | −0.1% |
| Q1 2026 | Aug 7, 2025 · After close | +4.6% |
| Q4 2025 | May 13, 2025 · After close | +4.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY2027 Earnings Presentation | Earnings | 34 slides | Nov 6, 2026 |
| Q1 FY27 Earnings Presentation | Earnings | 31 slides | Aug 7, 2026 |
| FY2026 Earnings Presentation | Earnings | 36 slides | May 15, 2026 |
| Q3 FY2026 Earnings Presentation | Earnings | 38 slides | Feb 6, 2026 |
| Q2 FY2026 Earnings Presentation | Earnings | 38 slides | Nov 7, 2025 |
| Q1 FY26 Earnings Presentation | Earnings | 32 slides | Aug 8, 2025 |
| FY2025 Earnings Presentation | Earnings | 23 slides | May 14, 2025 |
| Q3 FY2025 Earnings Presentation | Earnings | 23 slides | Feb 25, 2025 |
| Q3 FY2025 Earnings Presentation | Earnings | 22 slides | Feb 24, 2025 |
| Q3 FY2025 Earnings Presentation | Earnings | 22 slides | Feb 7, 2025 |
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 21.9B | 17.0B | 14.6B | 12.0B | 8.69B | 7.60B |
| Cost of revenue | 14.2B | 12.7B | 9.69B | 8.79B | 6.02B | 2.45B |
| Gross profit | 7.72B | 6.19B | 4.88B | 3.18B | 2.67B | 5.15B |
| Selling, general and administrative | 774.9M | 351.4M | 393.0M | 225.9M | 262.3M | |
| Operating income | 4.64B | 2.73B | 1.81B | 768.3M | 354.7M | 2.82B |
| Depreciation and amortization | 1.67B | 1.39B | 1.19B | 994.3M | 901.6M | 795.7M |
| EBITDA | 6.31B | 4.12B | 3.01B | 1.76B | 1.26B | 3.62B |
| Interest expense | 392.4M | 783.4M | 859.1M | 770.6M | 495.7M | |
| Income before tax | 4.66B | 2.28B | 1.09B | 164.1M | 97.0M | 819.2M |
| Income tax | 1.17B | 575.7M | 264.3M | 64.2M | 34.7M | 208.2M |
| Net income | 3.49B | 1.70B | 828.1M | 99.9M | 62.3M | 611.0M |
| Earnings per share, basic | 16.43 | 8.61 | 3.98 | 0.48 | 0.30 | 3.54 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 1.11B | 911.2M | 236.6M | 699.1M | 1.16B | 667.5M |
| Short-term investments | 469.9M | 2.81B | 1.61B | 1.35B | 1.00B | 1.25B |
| Receivables | 3.74B | 7.87B | 5.90B | 4.97B | 4.94B | 4.22B |
| Inventory | 1.51B | 1.19B | 874.4M | 1.40B | 1.27B | 763.5M |
| Current assets | 14.1B | 15.0B | 9.45B | 9.64B | 9.45B | 8.04B |
| Total assets | 36.3B | 31.6B | 22.8B | 21.9B | 21.6B | 18.2B |
| Accounts payable | 2.85B | 3.23B | 1.38B | 2.09B | 1.99B | 1.38B |
| Current liabilities | 8.34B | 7.32B | 7.40B | 7.59B | 7.15B | 5.99B |
| Long-term debt | 205.0M | 0 | 2.77B | 2.61B | 2.97B | |
| Total debt | 2.88B | 3.52B | 9.28B | 9.32B | 9.65B | 6.75B |
| Total liabilities | 11.4B | 10.3B | 13.0B | 13.0B | 12.9B | 9.54B |
| Shareholders' equity | 24.8B | 21.3B | 9.75B | 8.88B | 8.79B | 8.63B |
| Shares outstanding | 212.4M | 197.6M | 208.0M | 208.0M | 208.0M | 172.4M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Cash from operations | 5.21B | 2.77B | 2.63B | 2.19B | 1.05B | -363.8M |
| Capital spending | -5.93B | -3.69B | -1.82B | -1.13B | -2.07B | -2.62B |
| Free cash flow | -721.3M | -918.4M | 814.0M | 1.06B | -1.02B | -2.98B |
| Cash from investing | -4.18B | -5.53B | -1.92B | -1.02B | -1.04B | -2.60B |
| Cash from financing | -1.13B | 3.54B | -953.0M | -2.01B | 719.2M | 2.95B |
| Change in cash | -1.14B | 1.87B | -235.6M | -802.5M | 751.5M | 406.2M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Sai Life Sciences Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "Press Release on Financial Results ". | Nov 5, 2026 | Results | NSE India |
| Sai Life Sciences Ltd. Press Release Aug 06 2026 | Aug 6, 2026 | Results | NSE India |
| Press Release May 14 2026 | May 14, 2026 | Results | NSE India |
| Press Release May 11 2026 | May 11, 2026 | Other filings | NSE India |
| Press Release Feb 05 2026 | Feb 5, 2026 | Other filings | NSE India |
| Press Release Jan 28 2026 | Jan 28, 2026 | Operations update | NSE India |
| Press Release Dec 19 2025 | Dec 19, 2025 | ESG report | NSE India |
| Press Release Nov 11 2025 | Nov 11, 2025 | Other filings | NSE India |
| Press Release Nov 06 2025 | Nov 6, 2025 | Other filings | NSE India |
| Press Release Oct 27 2025 | Oct 27, 2025 | Operations update | NSE India |
All 17 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Press Release Oct 08 2025 | Oct 8, 2025 | Other filings | NSE India |
| Press Release Sep 18 2025 | Sep 18, 2025 | Operations update | NSE India |
| Press Release Aug 28 2025 | Aug 28, 2025 | Operations update | NSE India |
| Press Release Aug 08 2025 | Aug 8, 2025 | Results | NSE India |
| Press Release May 14 2025 | May 14, 2025 | Results | NSE India |
| Press Release Apr 03 2025 | Apr 3, 2025 | Operations update | NSE India |
| Press Release Feb 06 2025 | Feb 6, 2025 | Results | NSE India |
Cap table
Built by 6ix from SAI Life Sciences Ltd.’s releases
- Common shares
- 212,472,716
- Fully diluted
- 212,472,716
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 212,472,716 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 212,472,716 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Dinesh V Patel | Independent Director · Since at least Nov 5, 2026 |
| Kanumuri Ranga Raju | Chairman · Since at least Nov 5, 2026 |
| K. Ranga Raju | Chairman · Since at least Nov 5, 2026 |
| Krishna Kanumuri | Managing Director and CEO · Since at least Feb 20, 2026 |
| Ramesh G Iyer | Independent Director · Since at least Nov 5, 2026 |
| Runa Karan | Company Secretary, Compliance Officer & Legal Head · Since at least Nov 5, 2026 |
| Siva Chittor | Whole-Time Director & Chief Financial Officer · Since at least Aug 8, 2025 |
| Sriram Gopalakrishnan | Vice President · Since at least Dec 19, 2025 |
| Suchita Sharma | Independent Director · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about SAI Life Sciences Ltd.